289 results on '"Jacqmin, Didier"'
Search Results
2. Supplementary Figure 4 from Targeting the Nuclear Factor-κB Rescue Pathway Has Promising Future in Human Renal Cell Carcinoma Therapy
3. Supplementary Tables 1-2 from Targeting the Nuclear Factor-κB Rescue Pathway Has Promising Future in Human Renal Cell Carcinoma Therapy
4. Supplementary Figure 6 from Targeting the Nuclear Factor-κB Rescue Pathway Has Promising Future in Human Renal Cell Carcinoma Therapy
5. Supplementary Legends 1-6 from Targeting the Nuclear Factor-κB Rescue Pathway Has Promising Future in Human Renal Cell Carcinoma Therapy
6. Supplementary Figure 2 from Targeting the Nuclear Factor-κB Rescue Pathway Has Promising Future in Human Renal Cell Carcinoma Therapy
7. Supplementary Figure 1 from Targeting the Nuclear Factor-κB Rescue Pathway Has Promising Future in Human Renal Cell Carcinoma Therapy
8. Supplementary Figure 3 from Targeting the Nuclear Factor-κB Rescue Pathway Has Promising Future in Human Renal Cell Carcinoma Therapy
9. Supplementary Figure 5 from Targeting the Nuclear Factor-κB Rescue Pathway Has Promising Future in Human Renal Cell Carcinoma Therapy
10. Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project
11. Angiography as a Diagnostic Tool in Renal Cell Carcinoma
12. Constitutively Active Androgen Receptor Variant Detected in a Human Prostate Cancer
13. Hexaminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis and Follow-Up of Patients with Non–Muscle-Invasive Bladder Cancer: Review of the Evidence and Recommendations
14. Photodynamic Diagnosis in Non–Muscle-Invasive Bladder Cancer: A Systematic Review and Cumulative Analysis of Prospective Studies
15. The Expanding Role of Partial Nephrectomy: A Critical Analysis of Indications, Results, and Complications
16. Targeting FAK scaffold functions inhibits human renal cell carcinoma growth
17. Prognostic Value of Renal Vein and Inferior Vena Cava Involvement in Renal Cell Carcinoma
18. Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881
19. Partial Versus Radical Nephrectomy in Patients With Adverse Clinical or Pathologic Characteristics
20. Percutaneous MR-guided cryoablation of prostate cancer: initial experience
21. Photodynamic Diagnosis in Non-Muscle-Invasive Bladder Cancer
22. Correlation of introital ultrasound with LUTS after sling surgery
23. Transvaginal tape lysis for urinary obstruction after suburethral tape placement. When to do an immediate replacement?
24. MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses
25. Collecting Duct Renal Cell Carcinoma: A Matched Analysis of 41 Cases
26. Relationship between Age at Diagnosis and Clinicopathologic Features of Renal Cell Carcinoma
27. La néphrolithotomie percutanée “tubeless” : à propos de 37 cas
28. Vitamin D3 triggers antitumor activity through targeting hedgehog signaling in human renal cell carcinoma
29. Role of the RNA-binding protein HuR in human renal cell carcinoma
30. Survival of patients with nonmetastatic pT3 renal tumours: a matched comparison of laparoscopic vs open radical nephrectomy
31. von Hippel-Lindau tumor suppressor gene-dependent mRNA stabilization of the survival factor parathyroid hormone-related protein in human renal cell carcinoma by the RNA-binding protein HuR
32. Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma
33. INTERREGULATION OF AKT KINASE, NF-kB AND GLYCOGEN SYNTHASE KINASE-3 IN HUMAN RENAL CELL CARCINOMA: A VON HIPPEL-LINDAU TUMOR SUPPRESSOR GENE-DEPENDENT MECHANISM OF CELL SURVIVAL: 246
34. TARGETING THE RNA-BINDING PROTEIN HuR HAS POTENT ANTI-TUMOR EFFECTS IN HUMAN RENAL CELL CARCINOMA: 101
35. BLOCKADE OF FOCAL ADHESION KINASE (FAK) HAS POTENT ANTI-TUMOR ACTIVITIES IN HUMAN RENAL CELL CARCINOMA: 102
36. Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K–Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B
37. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up
38. Prognostic Value of Microscopic Venous Invasion in Renal Cell Carcinoma: Long-Term Follow-Up
39. Prognostic Value of Multifocality on Progression and Survival in Localized Renal Cell Carcinoma
40. Cancer du rein – Actualités — Diagnostics et thérapeutiques
41. Pathology and Genetics in Renal Cell Cancer
42. Contrast Enhances Color Doppler Endorectal Sonography of Prostate: Efficiency for Detecting Peripheral Zone Tumors and Role for Biopsy Procedure
43. Molecular Analysis of Urine Sediment for Follow-up of Urinary Tract Cancers
44. The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth
45. MP72-19 PHASE II STUDY OF AXITINIB FOR DOWNSTAGING CT2A TO CT1 RENAL TUMORS FOR ALLOWING PARTIAL NEPHRECTOMY (AXIPAN)
46. Primary CIC-DUX4 round cell sarcoma of the kidney: A treatment-refractory tumor with poor outcome
47. Observational Studies Requested by European Health Authorities: Governmental Interference or an Enhancement of Everyday Urological Practice? The Hexvix® Observational Patients Evaluation Study as an Example of What to Expect
48. Phase II study of axitinib for downstaging cT2a to cT1 renal tumors for allowing partial nephrectomy (AXIPAN).
49. Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†.
50. Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: Evidence review and updated expert recommendations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.